Doctor walking down hospital corridor.
Our Work

Latham & Watkins Advises Fresenius on Sale of Vamed’s Rehabilitation Business

May 3, 2024
A corporate team represents global healthcare group on divestment of majority stake in rehabilitation business.

Latham & Watkins LLP has advised global healthcare group Fresenius on the sale of the majority of Vamed’s rehabilitation business to PAI Partners (PAI). Upon completion of the transaction, PAI will become the majority owner of the new company with 67%, while Fresenius will retain 33%. The rehabilitation business comprises 67 facilities with 9,100 beds and around 9,500 employees (FTE) across Germany, Austria, Switzerland, the Czech Republic, and the UK.

Fresenius SE was inhouse represented with a legal team led by head of legal M&A/ Transformation Jan Winzen with Katharina Engels, Lisa Schickling, and Lukas Fleck.

Latham & Watkins LLP represented Fresenius with a team led by corporate partner Tobias Larisch, with counsel Lucas Schweitzer and associates Katharina Intfeld, Jaschar Mirkhani, Jakob Baldes, Katharina Steinbrueck, Alexander Pfeifer, and Jan Gocha. Advice was also provided healthcare regulatory matters by partner Christoph Engeler and associate Henrietta Ditzen; on tax matters by partner Tobias Klass and associate Manuela Minsel; on corporate IP matters by partner Susan Kempe Mueller and associate Daniela Jaeger; on finance matters by associate Ralph Draeger; on antitrust matters by partner Max Hauser and associate Helena Hofmann; on employment matters by partner Tobias Leder and associate Christian Strauß; on real estate matters by counsel Sven Nickel and associate Marie-Christine Welp.